(Q33804255)

29 July 2017

Blood-based biomarkers for Parkinson's disease (English)

1 reference

29 July 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

2

Matthew B Stern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Alice Chen-Plotkin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

1 January 2014

1 reference

Parkinsonism and Related Disorders

29 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

20 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

S99-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

8 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Prospective study of statin use and risk of Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

The Parkinson Progression Marker Initiative (PPMI).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Sensitive and specific detection of α-synuclein in human plasma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Peripheral inflammatory biomarkers and risk of Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Plasma urate and risk of Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Molecular markers of early Parkinson's disease based on gene expression in blood

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Inflammation and neurodegeneration in Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Discontinuation of statin therapy associates with Parkinson disease: a population-based study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Serum uric acid levels and the risk of Parkinson disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4070332

Toward a redefinition of Parkinson's disease

30 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970025-7

7 January 2021

Secretion of DJ-1 into the serum of patients with Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24262199

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1353-8020(13)70025-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24262199%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference